However, a recent single-center study with service populations in the Taipei metropolitan area estimated that the incidence of recent hepatitis C among HIV-infected MSM was 1.23 per 100 person-years, an incidence level in support of the currently endorsed screening strategy (6-month ALT and 12-month HCV) [30, 56]. The gene discussed is GPT; the disease is hepatitis C virus infection.